Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBFB | Q13951 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.49 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.48 |
| ▸ | NQO2 | P16083 | 4/20 | 0.44 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9306381 | 0.83 | CBFB (0.59) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL1170818 | 0.81 | CBFB (0.69) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL4611125 | 0.80 | ALDH1A1 (0.55) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL4420446 | 0.80 | ALDH1A1 (0.55) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL215705 | 0.79 | CYP3A4 (0.54) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL6935068 | 0.79 | ALDH1A1 (0.54) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL941420 | 0.79 | HPGD (0.54) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL6650618 | 0.79 | CYP3A4 (0.54) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL24276142 | 0.77 | CBFB (0.49) | CBFBALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL19170937 | 0.76 | HSD17B10 (0.51) | CBFBALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240384067-A1 | CHLOROPRENE-BASED POLYMER LATEX COMPOSITION, AND DIP-MOLDED ARTICLE | DENKA COMPANY LIMITED (JP) | 2024-11-21 | — | — | US | disclosed |
| CN-118974159-A | Impregnation-molded article, chloroprene-based polymer, and method for producing impregnation-molded article | 电化株式会社 | 2024-11-15 | — | — | CN | disclosed |
| CN-118946622-A | Process for producing chloroprene polymer composition | 电化株式会社 | 2024-11-12 | — | — | CN | disclosed |
| CN-118946624-A | Chloroprene polymer and dip-molded article | 电化株式会社 | 2024-11-12 | — | — | CN | disclosed |
| CN-118946623-A | Chloroprene polymer composition, chloroprene polymer latex, and dip-molded article | 电化株式会社 | 2024-11-12 | — | — | CN | disclosed |
| EP-4389815-A1 | CHLOROPRENE-BASED POLYMER LATEX COMPOSITION, AND DIP-MOLDED ARTICLE | Denka Company Limited (JP) | 2024-06-26 | — | — | EP | disclosed |
| CN-117980395-A | Chloroprene type polymer latex composition and dip-molded article thereof | 电化株式会社 | 2024-05-03 | — | — | CN | disclosed |
| WO-2023188802-A1 | CHLOROPRENE-BASED POLYMER COMPOSITION, CHLOROPRENE-BASED POLYMER LATEX, AND DIP-MOLDED ARTICLE | デンカ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190144-A1 | CHLOROPRENE POLYMER AND DIP-MOLDED PRODUCT | デンカ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023188801-A1 | METHOD FOR PRODUCING CHLOROPRENE-BASED POLYMER COMPOSITION | デンカ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-7425634-B2 | Benzimidazole compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
| US-7425634-B2 | Benzimidazole compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
| EP-1870409-A1 | BENZIMIDAZOLE COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
| EP-1870409-A1 | BENZIMIDAZOLE COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
| US-20070015782-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070015782-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070015782-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070010542-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-11 | — | — | US | disclosed |
| US-20070010542-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-11 | — | — | US | disclosed |
| US-20070010542-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010542-A1 | Benzimidazole compound | HRH2, GIPR, HRH4 | CBFB 4357/4885ALDH1A1 1028/4885CYP3A4 1499/4885 |
| US-20070015782-A1 | Benzimidazole compound | HRH2, GIPR, HRH4 | CBFB 4357/4885ALDH1A1 1028/4885CYP3A4 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.